Comparative Effects of Antidiabetic Drug, Metformin and Deferoxamine, on Serum Lipids, Serum Ferritin and Endocrine Indicators of Diabetes Mellitus Complications in Sreptozotocin Diabetic Rats

References (33)

1. 1 Iron-Chelating Therapy and the Treatment of Thalassemia [DOI]
2. 2 Experimental NIDDM: Development of a New Model in Adult Rats Administered Streptozotocin and Nicotinamide [DOI]
3. 3 Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial [DOI]
4. 4 Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus [DOI]
5. 5 The Role of Iron in Diabetes and Its Complications [DOI]
6. 6 Oral Pharmacologic Treatment of Type 2 Diabetes Mellitus: A Clinical Practice Guideline From the American College of Physicians [DOI]
7. 7 Cardiac morbidity and mortality in deferoxamine- or deferiprone-treated patients with thalassemia major [DOI]
8. 8 Adipocyte iron regulates adiponectin and insulin sensitivity [DOI]
9. 9 Deferoxamine-induced attenuation of brain edema and neurological deficits in a rat model of intracerebral hemorrhage [DOI]
10. 10 Effect of iron depletion in carbohydrate-intolerant patients with clinical evidence of nonalcoholic fatty liver disease [DOI]
11. 11 Dietary iron restriction or iron chelation protects from diabetes and loss of β-cell function in the obese (ob/ob lep−/−) mouse [DOI]
12. 12 Effects of phlebotomy-induced reduction of body iron stores on metabolic syndrome: results from a randomized clinical trial [DOI]
13. 13 Novel Mechanism for Plasma Glucose–Lowering Action of Metformin in Streptozotocin-Induced Diabetic Rats [DOI]
14. 14 Anti-diabetic properties of Tinospora cordifolia stem extracts on streptozotocin-induced diabetic rats. [DOI]
15. 15 In vivo antidiabetic and antioxidant potential of Helichrysum plicatum ssp. plicatum capitulums in streptozotocin-induced-diabetic rats [DOI]
16. 16 Desferrioxamine-chelatable iron, a component of serum non–transferrin-bound iron, used for assessing chelation therapy [DOI]
17. 17 Pathophysiological role and therapeutic implications of inflammation in diabetic nephropathy [DOI]
18. 18 Antidiabetic and ameliorative potential of Ficus bengalensis bark extract in streptozotocin induced diabetic rats [DOI]
19. 19 Effect of Ethanolic Extract of Juglans regia L. on Blood Sugar in Diabetes-Induced Rats [DOI]
20. 20 Hepatoprotective effect of tualang honey supplementation in streptozotocin-induced diabetic rats
21. 21 An investigation on body weights, blood glucose levels and pituitary-gonadal axis hormones in diabetic and metformin-treated diabetic female rats.
22. 22 Antidiabetic effect of burdock (Arctium lappa L.) root ethanolic extract on streptozotocin-induced diabetic rats [DOI]
23. 23 The effect of hydro alcoholic extract of Juglans regia leaves in streptozotocin-nicotinamide induced diabetic rats.
24. 24 Iron Chelator Triggers Inflammatory Signals in Human Intestinal Epithelial Cells: Involvement of p38 and Extracellular Signal-Regulated Kinase Signaling Pathways [DOI]
25. 25 Relationship between Serum Ferritin and Type-2 Diabetes Mellitus
26. 26 Evaluation Of Anti-Diabetics And Cardiovascular Effects Of Parinari Curatellifolia Seed Extract And Anthoclista Vogelli Root Extract Individually And Combined On Postprandial And Alloxan-Induced Diabetic Albino Rats [DOI]
27. 27 Pioglitazone versus metformin in two rat models of glucose intolerance and diabetes.
28. 28 Ethanolic Extract of Ocimum Grattissimum Leaves (Linn.) Rapidly Lowers Blood Glucose Levels in Diabetic Wistar Rats [DOI]
29. 29 The effect of metformin and exercise on serum lipids, nitric oxide synthase and liver nitric oxide levels in streptozotocin-nicotinamide induced diabetic rats [DOI]
30. 30 Comparative therapeutic potentials of acarbose and a formulated herbal extract on type 2 diabetic rats [DOI]
31. 31 Protection by Deferoxamine from Endothelial Injury: A Possible Link with Inhibition of Intracellular Xanthine Oxidase [DOI]
32. 32 Effect of a novel insulinotropic agent, succinic acid monoethyl ester, on lipids and lipoproteins levels in rats with streptozotocin-nicotinamide-induced type 2 diabetes [DOI]
33. 33 Role of Iron in the Pathogenesis of Diabetes and Metabolic Syndrome [DOI]

Cited by 5

Showing 2 of 5 known citations — external sources report more than can currently be individually listed.

Related research

• Risk Factors of Hypertension among Type 2 Diabetic Patients in Imo state, South East of Nigeria — shares topic coverage
• Patient-Related Factors Affecting Type 2 Diabetes Medication Non-Adherence: A Comprehensive Review of BMI, Knowledge Levels, Treatment Concerns, and Self-Efficacy — shares topic coverage
• The Prevalence of Microalbuinuria & Associated Risk Factors at the Time of Diagnosis among Type 2 Diabetic Patients in Rajshahi City, Bangladesh — shares topic coverage
• Integrating Sglt-2 Inhibitors into the Clinical Management of Type 2 Diabetes Mellitus and Chronic Kidney Disease: Current Evidence and Future Outlook — shares topic coverage
• Comparative Effects of Psyllium and Methylcellulose on LDL Cholesterol and Glycemic Control in Type 2 Diabetes Patients: A Systematic Review and Meta-Analysis — shares topic coverage